As a new uremic toxin and potential biomarker, TMAO is involved in changes in the heart-gut-kidney axis, including neuroendocrine activation, hemodynamic changes, alterations in gut microbiota, and intestinal congestion (Xiong et al., 2023)
Understanding how peptides compare to SARMs is also useful for anyone evaluating different classes of performance and body composition compounds
Keywords: GLP-1R agonists, obesity, weight-reducing drugs, metabolic diseases, dual agonism 1
E., & Berridge, C
The peptide stimulates collagen synthesis across various connective tissues
The 3-hydroxypyruvate can then converted to glycoaldehyde via the action of glyoxylate and hydroxypyruvate reductase (encoded by the GRHPR gene)